You are here

ficlatuzumab

Aveo regains full rights to ficlatuzumab as partner splits before phase 3

Fierce Biotech

Tue, 09/8/20 - 10:39 pm

clinical trials

Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19

Fierce Biotech

Mon, 03/30/20 - 10:33 am

clinical trials

Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab

Yahoo/Fly on the Wall

Mon, 10/1/12 - 10:41 am

non-small cell lung cancer